Leerink Partners Raises Price Target on Globus Medical (GMED) Following 2Q Results

Go back to Leerink Partners Raises Price Target on Globus Medical (GMED) Following 2Q Results

Globus Medical (GMED) Reports In-Line Q2 EPS

July 30, 2015 4:44 PM EDT

Globus Medical (NYSE: GMED) reported Q2 EPS of $0.25, in-line with the analyst estimate of $0.25. Revenue for the quarter came in at $133.6 million versus the consensus estimate of $126.89 million.

For earnings history and earnings-related data on Globus Medical (GMED) click here.

... More

Trading Radar for 7/30: P&G (PG), ConocoPhillips (COP), LinkedIn (LNKD), Expedia (EXPE), Electronic Arts (EA), Nokia (NOK) Report

July 29, 2015 2:50 PM EDT

The Trading Radar highlights key earnings and economic announcements for the next trading session:

Before Markets Open:
Economics:
8:30am EDT

Initial Claims - Street sees 272kContinuing Claims - Street sees 2.200MGDP: Adv. - Street sees 2.5%Chain Deflator: Adv. - Street sees 1.5%

Earnings:

02micro (Nasdaq: OIIM) - consensus loss $0.11
ACI Worldwide, Inc. (Nasdaq: ACIW) - consensus EPS $0.06
ADP (NYSE: ADP) - consensus EPS $0.60
Abengoa Yield (NYSE:... More